Table 3 Sensitivity analyses
Sensitivity analysis | Triglyceride levels (mmol/L, HR (95% CI)) | |||||
---|---|---|---|---|---|---|
<0.8 | 0.8–1.0 | 1.0–1.2 | 1.2–3.0 | 3.0–5.7 | ≥5.7 | |
Exclude death within 2 years after HF diagnosis | ||||||
N | 14,514 | 14,790 | 6778 | 38,913 | 1963 | 280 |
All-cause mortality | 1.19 (1.15–1.23) | 1.09 (1.06–1.12) | 1.06 (1.02–1.10) | 1.00 | 1.06 (1.01–1.13) | 1.14 (1.03–1.30) |
Cardiovascular deatha | 1.23 (1.18–1.28) | 1.13 (1.09–1.18) | 1.10 (1.04–1.15) | 1.00 | 1.07 (1.01–1.14) | 1.19 (1.05–1.37) |
Time-weighted average triglyceride (mmol/L) | ||||||
N | 22,789 | 24,921 | 11,674 | 64,423 | 2900 | 417 |
All-cause mortality | 1.39 (1.35–1.44) | 1.21 (1.17–1.24) | 1.10 (1.07–1.13) | 1.00 | 1.12 (1.06–1.17) | 1.94 (1.66–2.25) |
Cardiovascular deatha | 1.43 (1.37–1.49) | 1.26 (1.21–1.31) | 1.12 (1.08–1.16) | 1.00 | 1.08 (1.01–1.15) | 1.93 (1.56–2.40) |